Daniel Raynor - Director, Ani Pharmaceuticals Inc

As of March 19, 2018


Daniel Raynor Net Worth

  • Net worth is estimated to be at least $27.55M
  • Owns at least 289,003 units of Ani Pharmaceuticals Inc stock
  • Sold an estimated value of $15.91M in the last 5 years at Ani Pharmaceuticals Inc

Daniel Raynor Trading

  • Largest sale of shares was 200,000 units , worth over $12.6M on March 16, 2015
  • In total has made about 10 transactions over 5 years
  • Usually trades in March, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Ani Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 7,224 units bought on March 23, 2022 by Nikhil Lalwani worth over $200K
  • In the last 9 years, insiders at Ani Pharmaceuticals Inc sold an estimated value of $107.84M and bought an estimated value of $6.24M
  • The most active traders are Arthur Przybyl, President and CEO,  Charlotte C Arnold, Vice President and CFO,  and James G Marken, SVP OPS & PROD DEV
  • Insider trading is most common in April, with the busiest year in 2013

ANI PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1